These effects, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assist the concept of targeting ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. Importantly, these receptors were being located https://solanged935lhc5.ltfblog.com/profile